ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664401 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664401; 2) Community: the network communities that were significantly associated with the response to NSC 664401; 3) Molecule: the relationships between components within communities and NSC 664401; 4) MDR: the compounds that were significantly associated with the NSC 664401.

NSC Compound Enrichment Correlation
NSC 116878 Cardiac glycoside 0.00414350254426684 -0.027912379
NSC 243022 Cinerubin A hydrochloride 0.00414350254426684 0.13833562
NSC 629736 Null 0.00414350254426684 0.1962892
NSC 639661 Null 0.00414350254426684 0.15101254
NSC 676184 Null 0.00414350254426684 0.39401405
NSC 683661 Acetic acid, amino-, 9-[[(amino)carbonyl]oxy]-13-(2-amino- 1-oxoethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl- 3,20,22-trioxo-19-[(2-propenyl)amino]-2-azabicyclo [16.3.1]docosa-1(21),4,6,10,18-pentae 0.00414350254426684 0.64784237
NSC 715067 Null 0.00414350254426684 0.3010425
NSC 740846 6-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one 0.00414350254426684 0.22753172
NSC 747558 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one 0.00414350254426684 0.40002584
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.0045408171545557 0.45838482
Total:66  Current:8    [First] [Prev] [Next] [Last]